Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.

The Journal of clinical psychiatry - 1 Jan 1996

Small G W

Abstract excerpt

Identifying persons with mild cognitive complaints who are at risk for Alzheimer's disease (AD) will enable the start of antidementia treatments before extensive brain damage develops. Recent research developments link the apolipoprotein E-4 (APOE-4) allele to late-onset familial and late-onset s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aged
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Family

Share to Genetic Techniques

Share to Genotype

Source

Identifiers

PMID: 9024331

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-9024331-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.PMID 9024331Read ↗

Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.Semantic proximity Read ↗

Differential diagnosis and early detection of dementia.Semantic proximity Read ↗

Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.Semantic proximity Read ↗

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Semantic proximity Read ↗

Pharmacogenomics in Alzheimer's disease.Semantic proximity Read ↗

Neuroimaging for diagnosis of dementia.Semantic proximity Read ↗

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.Semantic proximity Read ↗

Linking Brain Imaging and Genomics in the Study of Alzheimer's Disease and AgingSemantic proximity Read ↗

Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.Semantic proximity Read ↗

Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype).Semantic proximity Read ↗

Pharmacogenomics and therapeutic strategies for dementiaSemantic proximity Read ↗

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.